The following pages link to NO more muscle fatigue (Q43172685):
Displaying 17 items.
- Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy (Q27318308) (← links)
- Muscle fatigue, nNOS and muscle fiber atrophy in limb girdle muscular dystrophy (Q28083989) (← links)
- Subcellular and cellular locations of nitric oxide synthase isoforms as determinants of health and disease (Q28279612) (← links)
- Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy (Q30650948) (← links)
- Mechanisms of muscle weakness in muscular dystrophy (Q33950716) (← links)
- Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy (Q33991780) (← links)
- Distinct genetic regions modify specific muscle groups in muscular dystrophy (Q34518008) (← links)
- Dystrophic muscle improvement in zebrafish via increased heme oxygenase signaling. (Q35043351) (← links)
- Muscle exercise in limb girdle muscular dystrophies: pitfall and advantages. (Q35774675) (← links)
- Fatigue in muscular dystrophies (Q38062690) (← links)
- Genes for elite power and sprint performance: ACTN3 leads the way. (Q38107422) (← links)
- Associations Between Neurotransmitter Genes and Fatigue and Energy Levels in Women After Breast Cancer Surgery (Q46744795) (← links)
- Urethral sphincter fatigue after robot-assisted radical prostatectomy: descriptive questionnaire-based study and anatomic basis. (Q51090641) (← links)
- Fetal Development of the Human Obturator Internus Muscle With Special Reference to the Tendon and Pulley. (Q53615931) (← links)
- The −786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports (Q57892422) (← links)
- Relaxin counteracts the altered gastric motility of dystrophic (mdx) mice: functional and immunohistochemical evidence for the involvement of nitric oxide (Q64896382) (← links)
- Exercise therapy in muscle diseases: open issues and future perspectives (Q92863880) (← links)